Research Article: Population Sensitive to Lenvatinib Plus Anti-PD- for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus
Abstract:
Graphical Abstract:
Introduction:
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death globally. For most patients, the opportunity for complete resection is lost at the first diagnosis due to the lack of early symptoms. Therefore, about half of the HCC patients receive systemic therapies that are the standard for unresectable hepatocellular carcinoma (u-HCC) according to official guidelines. –
Read more